
Brand Name | Status | Last Update |
|---|---|---|
| aminosyn ii | New Drug Application | 2025-11-02 |
| aminosyn-pf | New Drug Application | 2025-10-17 |
| clinimix | New Drug Application | 2021-04-13 |
| clinimix e | New Drug Application | 2021-04-13 |
| clinisol | ANDA | 2018-06-01 |
| ibuprofen lysine | NDA authorized generic | 2026-04-06 |
| kabiven | New Drug Application | 2025-09-11 |
| lip clear lysine plus | C200263 | 2025-10-20 |
| lip clear lysine plus coldstick | C200263 | 2025-10-20 |
| livdelzi | New Drug Application | 2026-02-03 |
Patent | Expires | Flag | FDA Information |
|---|---|---|---|
| Ibuprofen Lysine, Neoprofen, Recordati Rare | |||
| 8415337 | 2032-03-02 | DS, DP | |

Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Sarcoma | D012509 | — | — | 2 | 2 | — | — | 1 | 4 |
| Synovial sarcoma | D013584 | — | — | 2 | 2 | — | — | 1 | 4 |
| Rhabdoid tumor | D018335 | — | — | 1 | 1 | — | — | 1 | 3 |
| Brain stem neoplasms | D020295 | EFO_1001767 | — | 1 | 2 | — | — | 1 | 3 |
| Neoplasms | D009369 | — | C80 | 2 | 2 | — | — | — | 3 |
| Malignant mesothelioma | D000086002 | — | — | — | 1 | — | — | 1 | 2 |
| Chordoma | D002817 | EFO_0000334 | — | — | 1 | — | — | 1 | 2 |
| Mesothelioma | D008654 | — | C45 | 1 | 2 | — | — | — | 2 |
| Prostatic neoplasms | D011471 | — | C61 | 1 | 1 | — | — | — | 1 |
| Castration-resistant prostatic neoplasms | D064129 | — | — | 1 | 1 | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Ovarian neoplasms | D010051 | EFO_0003893 | C56 | 1 | — | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Renal cell carcinoma | D002292 | EFO_0000376 | — | — | — | — | — | 1 | 1 |
| Small cell carcinoma | D018288 | — | — | — | — | — | — | 1 | 1 |
| Thoracic neoplasms | D013899 | — | — | — | — | — | — | 1 | 1 |
| Chondrosarcoma | D002813 | — | — | — | — | — | — | 1 | 1 |
| Glandular and epithelial neoplasms | D009375 | — | — | — | — | — | — | 1 | 1 |
| Desmoplastic small round cell tumor | D058405 | — | — | — | — | — | — | 1 | 1 |
| Drug common name | Lysine |
| INN | lysine |
| Description | Lysine is a diamino acid that is caproic (hexanoic) acid bearing two amino substituents at positions 2 and 6. It has a role as a Daphnia magna metabolite. It is an alpha-amino acid, a diamino acid and a polar amino acid. It contains a 4-aminobutyl group. It is functionally related to a hexanoic acid. It is a conjugate base of a lysinium(1+). It is a conjugate acid of a lysinate. |
| Classification | Small molecule |
| Drug class | — |
| Image (chem structure or protein) | ![]() |
| Structure (InChI/SMILES or Protein Sequence) | NCCCC[C@H](N)C(=O)O |
| PDB | — |
| CAS-ID | 56-87-1 |
| RxCUI | — |
| ChEMBL ID | CHEMBL8085 |
| ChEBI ID | 18019 |
| PubChem CID | 866 |
| DrugBank | DB00123 |
| UNII ID | K3Z4F929H6 (ChemIDplus, GSRS) |






